REGENERON PHARMACEUTICALS, INC. Inventory, Work in Process, Net of Reserves
REGENERON PHARMACEUTICALS, INC. (REGN) had Inventory, Work in Process, Net of Reserves of $1.51 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2026-07-30
- 2026-06-30: Inventory, Work in Process, Net of Reserves $1.51B.
- 2026-03-31: Inventory, Work in Process, Net of Reserves $1.52B.
- 2025-12-31: Inventory, Work in Process, Net of Reserves $1.64B.
- 2025-09-30: Inventory, Work in Process, Net of Reserves $1.57B.
| Period end | Inventory, Work in Process, Net of Reserves | Inventory, Work in Process, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $1.51B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $1.52B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $1.64B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $1.57B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $1.54B 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $1.47B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $1.34B 10-K · filed 2026-02-04 | |
| 2024-09-30 | $1.23B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $1.15B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $1.11B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $1.12B 10-K · filed 2025-02-05 | |
| 2023-09-30 | $1.12B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.07B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $855.70M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $963.10M 10-K · filed 2024-02-05 | |
| 2022-09-30 | $833.50M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $717.30M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $644.90M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $707.20M 10-K · filed 2023-02-06 | |
| 2021-09-30 | $843.70M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $741.10M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $971.20M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $904.60M 10-K · filed 2022-02-07 | |
| 2020-09-30 | $715.40M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $696.90M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $692.20M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $727.70M 10-K · filed 2021-02-08 | |
| 2019-09-30 | $633.50M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $663.10M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $581.30M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $571.10M 10-K · filed 2020-02-07 | |
| 2018-09-30 | $435.67M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $400.83M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $374.50M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $302.00M 10-K · filed 2019-02-07 | $302.04M 10-K · filed 2018-02-08 |
| 2017-09-30 | $217.45M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $162.72M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $173.47M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $202.30M 10-K · filed 2018-02-08 | |
| 2016-09-30 | $164.06M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $165.87M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $157.92M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $132.07M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $110.62M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $111.56M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $83.99M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $73.52M 10-K · filed 2016-02-11 | |
| 2014-09-30 | $70.97M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $60.11M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $47.86M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $35.87M 10-K · filed 2015-02-12 | |
| 2013-09-30 | $34.84M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $34.58M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $25.06M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $14.66M 10-K · filed 2014-02-13 | |
| 2011-12-31 | $8.85M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |